Edward Hu, PhD
Ophthalmology · Hiawatha, IANPI 1992913685
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $136,752 of the $159,833 with a category attached, or 85.6%. 17 manufacturers reported payments, led by Carl Zeiss Meditec Cataract Technology Inc. at 46.3% of the total. Reporting peaked in 2022 at $52,422 and has fallen 93.8% since, to $3,258 in 2025. Among ophthalmology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $764.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec Cataract Technology Inc.$74K
- Carl Zeiss Meditec, Inc.$55K
- Johnson & Johnson Surgical Vision, Inc.$25K
- Alcon$3K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
- Bausch & Lomb Americas Inc.$946
- plus $728 from 11 others
Across 31 payments — averaging $15,164 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Carl Zeiss Meditec Cataract Technology Inc.$270K
- Alcon Research LLC$151K
- Johnson & Johnson Surgical Vision, Inc.$49K
What the payments were for
- Consulting fees$136,75286%
- Speaking & faculty fees$7,9605%
- Travel & lodging$9,1976%
- Food & beverage$5,9244%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec Cataract Technology Inc. | 51 | $74,044 |
| Carl Zeiss Meditec, Inc. | 25 | $54,606 |
| Johnson & Johnson Surgical Vision, Inc. | 30 | $25,136 |
| Alcon | 58 | $2,993 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $1,379 |
| Bausch & Lomb Americas Inc. | 16 | $946 |
| The Cameron-ehlen Group, Inc. | 8 | $329 |
| Rxsight Inc | 2 | $157 |
| AbbVie | 3 | $71 |
| Glaukos Corporation | 1 | $42 |
| Biotissue Holdings Inc. | 1 | $24 |
| Ivantis, Inc | 1 | $23 |
| Rayner Intraocular Lenses Limited | 1 | $20 |
| Omeros Corporation | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $13 |
| Eyepoint US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis IOL$66,075
- miLOOP$25,657
- CATALYS SYSTEM$10,950
- CALLISTO eye$8,940
- VERACITY SURGICAL$7,200
- IOLMaster$5,280
- ARTEVO 800$3,960
- QUATERA 700$3,660
- CIRRUS HD-OCT$3,165
- VisuMax$3,060
- None Specified$2,934
- RESCAN 700$2,200
- CT Lucia$2,200
- IOLMaster 700$1,320
- Tecnis Multifocal Family of 1-piece IOLS$1,100
- Catalys Laser System$1,100
- Tecnis Symfony IOL$1,100
- Tecnis Symfony Toric IOL$1,100
- CIRRUS 6000 with AngioPlex$1,088
- CLARUS$1,088
How this compares
$159,833 in reported general payments places this provider in the 95th percentile of 172 ophthalmology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 1,694 | $89,850 |
| Ofloxacin | 985 | $13,042 |
| Ketorolac Tromethamine | 417 | $9,529 |
| CombiganBrimonidine Tartrate/Timolol | 18 | $4,093 |
| MoxifloxacinMoxifloxacin Hcl | 32 | $1,269 |
| Latanoprost | 44 | $528 |
| Tobramycin | 12 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCombigan | $71 | $4,09318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 172 ophthalmology providers in Iowa.
Other ophthalmology in Hiawatha
- Caroline WilsonHiawatha$14K
- Paul BoekeHiawatha$4K
- Michael AbramoffIowa City$158K
- Stephen RussellIowa City$137K
- Jared NielsenWest Des Moines$117K
- Matthew RauenWest Des Moines$108K
- Jason JonesSioux City$83K
- Christy BensonDes Moines$70K
- Alina DumitrescuIowa City$57K
- Keith CarterIowa City$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.